Related Experiment Video
Updated: Oct 17, 2025

The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
Impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study
Qiang Lian1, Jian Wang1, Yun Lian2
1Division of Orthopaedic Surgery, Department of Orthopaedics, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue, Guangzhou, 510515, Guangdong, China.
Insights
Valvular heart disease (VHD) and aortic stenosis (AS) increase mortality and complications following hip replacement surgery. These conditions are linked to higher costs and adverse outcomes, necessitating careful patient evaluation.
Area of Science:
- Cardiovascular Surgery
- Orthopedic Surgery
- Public Health
Background:
- Valvular heart disease (VHD) impacts hip replacement outcomes.
- Aortic stenosis (AS) is a specific VHD with clinical implications before hip arthroplasty.
Purpose of the Study:
- To investigate the influence of VHD on hip replacement.
- To analyze the clinical effects of AS preceding total/partial hip arthroplasty.
Main Methods:
- Retrospective cohort study using NIS database (2005-2014).
- Independent t-tests and chi-square tests for patient characteristics.
- Multivariate regression for correlations in demographics, comorbidities, complications, costs, and time.
Main Results:
- VHD present in 5.56% and AS in 0.03% of hip replacement patients.
- VHD associated with female patients, elective admission, higher comorbidity index, large/teaching hospitals, and urban locations.
- VHD is a risk factor for mortality, acute cardiac events, pulmonary edema, cerebrovascular events, and renal failure.
- AS patients are older, more likely female, and have elective admissions.
- AS linked to perioperative complications like cardiac events and hepatic failure.
- Both VHD and AS correlate with increased mortality and hospitalization costs.
Conclusions:
- VHD independently predicts higher mortality rates after hip arthroplasty.
- VHD is associated with increased surgical and medical complications post-hip replacement.
- VHD and AS necessitate careful perioperative management in hip replacement patients.
Background:
To study the impact of valvular heart disease (VHD) on hip replacement, particularly the clinical impactions of aortic stenosis before total/partial hip arthroplasty.
Methods:
This was a retrospective cohort study. Data on patients who had undergone hip replacement from 2005 to 2014 were extracted from the NIS database. Independent t test and chi-square test were used to analyze the essential characteristics of patients. Multivariate regression was used to estimate the correlation among demographics, comorbidities, complications, hospitalization costs, and time.
Results:
VHD accounted for 5.56% and AS accounted for 0.03% of the patients before hip replacement surgeries. Patients with VHD before hip replacement are related to the following characteristics: female patients (odds ratio [OR] = 1.15 [1.12-1.18]), elective admission (OR = 0.78 [0.76-0.80]), Charlson Comorbidity Index ≥3 (OR = 1.06 [1.03-1.08]), large-volume hospitals (OR = 1.13 [1.1-1.2]), teaching hospitals (OR = 5 4.4 [2.9-6.7]), and hospital location in urban areas (OR = 1.22 [1.2-1.3]). In addition, VHD is a risk factor for mortality and some acute postoperative medical complications, such as acute cardiac event (OR = 2.96 [2.87-3.04]), acute pulmonary edema (OR = 1.13 [1.06-1.21]), acute cerebrovascular event (OR = 1.22 [1.16-1.74]), and acute renal failure (OR = 1.22 [1.17-1.27]). It also has an impact on DVT/PE (OR = 0.89 [0.8-0.99]). Patients with AS before hip replacement have basic demographic characteristics like those of hip replacement patients with valvular disease. Patients with AS are older than those without AS before surgery (OR = 3.28 [2.27-4.75) and are related to the following characteristics: female patients (OR = 1.92 [1.32-2.8]) and elective admission (OR = 0.51 [0.36-0.75]). The perioperative period is limited to acute postoperative complications, such as acute cardiac events (OR = 2.50 [1.76-3.53]) and acute hepatic failure (OR = 7.69 [1.8-32.89]). Both valvular diseases and AS are associated with a higher mortality rate and hospitalization cost.
Conclusion:
VHD independently predicted mortality rate and surgical and medical complications after total/partial hip arthroplasty.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Valve Prolapse I: Introduction
Rheumatic Heart Disease I: Introduction

